# Vessel > Vendor-neutral programs that build the capability to run molecular tumor boards, from liquid biopsy to treatment decision. Faculty from European cancer centres. Public Ghost content for AI and LLM tooling. Use `/llms-full.txt` for consolidated page and post context. Append `.md` to any post or page URL to get the content in Markdown (for example, `/example-post.md`). ## Pages - [The only clinician's handbook for ctDNA you'll ever need](https://www.vesseldna.com/a-clinicians-handbook-for-ctdna.md) - * Understand which panel makes sense for your patient. * How is ctDNA detected from plasma? * Understand what tumor fraction means. * Learn how to interpret copy number data. * Get a grasp on variant interpretation. * Understand the latest bioinformatics behind future plasma DNA applications. Hi th… - [Account](https://www.vesseldna.com/account.md) - [Alpha Version - NGS Dissertation Seminar](https://www.vesseldna.com/alpha-version.md) - [Bringing CGP to Greek Pathology](https://www.vesseldna.com/bringing-cgp-to-greek-pathology.md) - [Where Professionals Meet to Accelerate Precision Oncology](https://www.vesseldna.com/home.md) - Experience a unique blend of expert guidance, immediately applicable content, and a community dedicated to building confidence and trust in the latest precision oncology approaches. - [Join Vessel Now](https://www.vesseldna.com/join-vessel-now-sign.md) - [Your North Star in the Transformation of Precision Oncology](https://www.vesseldna.com/membership.md) - Vessel Membership combines participation in focus groups with access to content and community to enable you and your team to bridge the gap of precision medicine and clinical application - [You're Offline.](https://www.vesseldna.com/offline.md) - It looks like you're currently offline. Try to get your connection back up - [Welcome to Vessel](https://www.vesseldna.com/signin.md) - To access your account, please sign in. - [Welcome to Vessel - Where Professionals meet to Accelerate Precision Oncology](https://www.vesseldna.com/signup.md) - Membership includes a seat in monthly live calls, and access to our immediately applicable content. - [SME](https://www.vesseldna.com/sme.md) - [Subscribe](https://www.vesseldna.com/subscribe.md) - [Tag](https://www.vesseldna.com/tag.md) - [Tags](https://www.vesseldna.com/tags.md) - [Terms of Service](https://www.vesseldna.com/terms.md) - Last updated: 12 June 2026 1. Provider Vessel FlexCo Kranewittergasse 20, 8042 Graz, Austria Company Register Number: 629078 s Commercial Register Court: Commercial Court of Graz VAT ID: ATU80912158 Email: office@vesseldna.com 2. Scope These Terms of Service govern your use of the website vesseldna… - [Application received](https://www.vesseldna.com/thank-you-for-your-application.md) - Thank you for your application We will be reviewing your application as soon as possible and will get back to you via e-mail. What to expect next After review of your application, you'll get an e-mail from us with your account credentials and further instructions Back to the Vessel Blog - [The Role of the Pathologist in NGS](https://www.vesseldna.com/the-role-of-the-pathologist-in-ngs.md) - Athens, July 2022 - [Vessel Application](https://www.vesseldna.com/vessel-application.md) - Apply to Vessel and join the community that accelerates precision oncology today! - [Vessel Slack Community Guidelines](https://www.vesseldna.com/vessel-slack-community.md) - [Welcome to Vessel](https://www.vesseldna.com/welcome-to-vessel.md) ## Posts - [Navigating the clinical ctDNA testing landscape: Assays, applications & approvals throughout the cancer patient journey](https://www.vesseldna.com/navigating-the-clinical-ctdna-testing-landscape.md) - Are you new to ctDNA testing strategies? Fear not! With this walk-through, we will guide you through some high-level concepts to help orient yourself in the current clinical landscape. - [VB04 - Let's interpret some variants (1)](https://www.vesseldna.com/vb04-variant-interpretation.md) - In this briefing, we walk you through a step-by-step process of the resources you can access to assess variant pathogenicity and actionability. - [Understanding and estimating tumor fraction from plasma cell-free DNA](https://www.vesseldna.com/understanding-and-estimating-tumor-fraction-from-plasma-cell-free-dna.md) - Vessel Tutorial - Understanding liquid biopsy results is highly dependent on tumor fraction of the cell-free DNA sample. Without information about ctDNA content from plasma, variant allele frequencies and uninformative testing results are very difficult to interpret. - [VB03 - Getting to know HRD testing](https://www.vesseldna.com/vb03-getting-to-know-hrd-testing.md) - [VB02 - Concordance of genomic results between tissue and liquid testing](https://www.vesseldna.com/vb02-concordance-of-genomic-results-between-tissue-and-liquid-testing.md) - Tissue and circulating tumor DNA testing can detect cancer alterations, but discrepancies in results can impact treatment decisions. This briefing discusses the basics and presents case studies. - [VB01 - Two CGP case studies from liquid biopsy](https://www.vesseldna.com/vb01-vessel-briefing.md) - Vessel Briefings are short sessions that are intended to not take too much time out of your busy schedule, but that still allow our community to interact on important topics. - [Fall 2022 dates - Bringing CGP to Greek pathology](https://www.vesseldna.com/fall-2022-focus-group.md) - [Bringing CGP to Greek Pathology](https://www.vesseldna.com/bringing-cgp-to-greek-pathology-2.md) - [How exactly does a Vessel program work?](https://www.vesseldna.com/how-exactly-does-such-a-program-work.md) - Get the low down of what to expect during the program and how to engage with your peers. - [Getting Started](https://www.vesseldna.com/getting-started.md) - [ctDNA profiling case studies](https://www.vesseldna.com/ctdna-profiling.md) - In this condensed tutorial, Vessel presents three real-world cases of patients with confirmed progressive disease in which liquid biopsy was used to identify actionable targets. The tutorial also includes a brief summary of the patient's history and the results of the liquid biopsy. - [Our Mission](https://www.vesseldna.com/our-mission.md) - Vessel focuses on providing end-to-end consulting in molecular tumor profiling. We aim to bridge the gap between precision medicine and clinical application, and offer programs to help remove barriers to implementing these approaches. ## Optional - [RSS Feed](https://www.vesseldna.com/rss/) - [Sitemap](https://www.vesseldna.com/sitemap.xml) - [Full content of pages and posts](https://www.vesseldna.com/llms-full.txt)